NCT00331994View on ClinicalTrials.gov

EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth

PHASE4CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Irritable Bowel Syndrome

Interventions

DRUG

Bacillus clausii

3 bacillus clausii vials/day for one month

DRUG

Metronidazole

3 Metronidazole tablets/day for one week

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Milan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00331994 - EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth | Biotech Hunter | Biotech Hunter